Antimicrobial resistance is a global health emergency.
The growing number of drug-resistant pathogens is making common infections more and more difficult to treat.
Gram-negative bacteria, a major cause of infections in recent years, are resistant to almost all antibiotics, leaving no option for treatment at all. BREAKthrough is a Doctoral Network which aims to make these bacteria susceptible to today’s standard-of-care antibiotics.
Since the bacteria’s outer membrane prevents antibiotics from entering the cell, the project will develop new compounds that ultimately damage the outer membrane and allow antibiotics to break through the bacterial cell wall.
BREAKthrough is funded under Horizon Europe’s Marie Skłodowska-Curie Actions (MSCA) programme (grant no. 101072632). Views and opinions expressed here are of the authors only.
Company Details
- Employees
- 2
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Breakthrough_dn Questions
Breakthrough_Dn's LinkedIn profile is https://www.linkedin.com/company/breakthrough-dn
Breakthrough_Dn has
2 employees.
View email and phone details for 2
employees at Breakthrough_Dn.
Breakthrough_Dn's industry is
Research Services
Breakthrough_Dn's top competitors are
Accelopment,
Centre For Innovation Excellence In Livestock (Ciel),
Cresco Innovation,
Envision,
Svennis | Premium Zoho Partner,
Ahti – Amsterdam Health & Technology Institute,
Aps Type 1 Foundation,
Stil Vor Talent Gmbh,
Axscend | Fleet Technologies,
Tbat Innovation Ltd.
Breakthrough_Dn's categories are Research Services
